Maya Koren-Michowitz

InstitutionTel Aviv University
AddressIsrael
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 2 publications in July 2021
    All Publications
    Bar chart showing 42 publications over 17 distinct years, with a maximum of 4 publications in 2010 and 2011 and 2014 and 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Levy I, Lavi A, Zimran E, Grisariu S, Aumann S, Itchaki G, Berger T, Raanani P, Harel R, Aviv A, Lavi N, Zuckerman T, Shvidel L, Jarchowsky O, Ellis M, Herzog Tzarfati K, Koren-Michowitz M, Sherf Y, Levi I, Sofer O, Shpilberg O, Dally N, Suriu C, Braester A, Ben Barouch S, Leiba M, Goldstein D, Sarid N, Yeganeh S, Halloun J, Mittelman M, Tadmor T. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leuk Lymphoma. 2021 12; 62(14):3384-3393. PMID: 34405767.
      Citations:    Fields:    Translation:Humans
    2. Herzog Tzarfati K, Gutwein O, Apel A, Rahimi-Levene N, Sadovnik M, Harel L, Benveniste-Levkovitz P, Bar Chaim A, Koren-Michowitz M. BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies. Am J Hematol. 2021 10 01; 96(10):1195-1203. PMID: 34185336.
      Citations: 14     Fields:    Translation:Humans
    3. Maayan H, Kirgner I, Gutwein O, Herzog-Tzarfati K, Rahimi-Levene N, Koren-Michowitz M, Blickstein D. Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine. J Thromb Haemost. 2021 09; 19(9):2314-2317. PMID: 34105247.
      Citations: 3     Fields:    Translation:Humans
    4. Ledergor G, Weiner A, Zada M, Wang SY, Cohen YC, Gatt ME, Snir N, Magen H, Koren-Michowitz M, Herzog-Tzarfati K, Keren-Shaul H, Bornstein C, Rotkopf R, Yofe I, David E, Yellapantula V, Kay S, Salai M, Ben Yehuda D, Nagler A, Shvidel L, Orr-Urtreger A, Halpern KB, Itzkovitz S, Landgren O, San-Miguel J, Paiva B, Keats JJ, Papaemmanuil E, Avivi I, Barbash GI, Tanay A, Amit I. Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma. Nat Med. 2018 12; 24(12):1867-1876. PMID: 30523328.
      Citations: 64     Fields:    Translation:HumansCells
    5. Koren-Michowitz M. Genetic Predisposition to Myeloproliferative Neoplasms: Another Piece of the Puzzle. Acta Haematol. 2018; 139(4):238-239. PMID: 29945137.
      Citations:    Fields:    Translation:Humans
    6. Rahimi-Levene N, Ziv-Baran T, Peer V, Golik A, Kornberg A, Zeidenstein R, Koren-Michowitz M. Hemoglobin transfusion trigger in an internal medicine department - A "real world" six year experience. PLoS One. 2018; 13(3):e0193873. PMID: 29513750.
      Citations: 1     Fields:    Translation:Humans
    7. Rahimi-Levene N, Koren-Michowitz M, Zeidenstein R, Peer V, Golik A, Ziv-Baran T. Lower hemoglobin transfusion trigger is associated with higher mortality in patients hospitalized with pneumonia. Medicine (Baltimore). 2018 Mar; 97(12):e0192. PMID: 29561440.
      Citations: 2     Fields:    Translation:Humans
    8. Ellis MH, Koren-Michowitz M, Lavi N, Vannucchi AM, Mesa R, Harrison CN. Ruxolitinib for the management of myelofibrosis: Results of an international physician survey. Leuk Res. 2017 10; 61:6-9. PMID: 28843161.
      Citations: 2     Fields:    Translation:Humans
    9. Koren-Michowitz M, Lavi N, Ellis MH, Vannucchi AM, Mesa R, Harrison CN. Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey. Ann Hematol. 2017 Jan; 96(1):87-92. PMID: 27734130.
      Citations: 3     Fields:    Translation:Humans
    10. Beider K, Rosenberg E, Bitner H, Shimoni A, Leiba M, Koren-Michowitz M, Ribakovsky E, Klein S, Olam D, Weiss L, Wald H, Abraham M, Galun E, Peled A, Nagler A. The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway. Clin Cancer Res. 2017 Apr 01; 23(7):1733-1747. PMID: 27697999.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    11. Ellis MH, Lavi N, Mishchenko E, Dally N, Lavie D, Courevitch A, Gutwein O, Bulvik S, Braester A, Chubar E, Tavor S, Duek A, Kirgner I, Koren-Michowitz M. Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice. Leuk Res. 2015 Aug 12. PMID: 26364797.
      Citations: 5     Fields:    
    12. Koren-Michowitz M, Shimoni A, Daraio F, Crasto F, Lorenzatti R, Volchek Y, Amariglio N, Gottardi E, Saglio G, Nagler A. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients. Biol Blood Marrow Transplant. 2015 Oct; 21(10):1852-5. PMID: 26151304.
      Citations: 3     Fields:    Translation:Humans
    13. Barbarov I, Koren-Michowitz M, Schiby G, Portnoy O, Livingstone D, Segal G. Fulminant HHV-8 associated Castleman's disease in a non-HIV, Kaposi sarcoma patient with borderline hemophagocytic syndrome. Isr Med Assoc J. 2015 Apr; 17(4):253-5. PMID: 26040056.
      Citations:    Fields:    Translation:HumansCells
    14. Beider K, Bitner H, Leiba M, Gutwein O, Koren-Michowitz M, Ostrovsky O, Abraham M, Wald H, Galun E, Peled A, Nagler A. Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype. Oncotarget. 2014 Nov 30; 5(22):11283-96. PMID: 25526031.
      Citations: 50     Fields:    Translation:HumansCells
    15. Shimoni A, Volchek Y, Koren-Michowitz M, Varda-Bloom N, Somech R, Shem-Tov N, Yerushalmi R, Nagler A. Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer. 2015 Mar 15; 121(6):863-71. PMID: 25387866.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    16. Koren-Michowitz M, Maayan H, Apel A, Shem-Tov N, Yerushalmi R, Volchek Y, Avigdor A, Shimoni A, Nagler A. Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation. Ann Hematol. 2015 Mar; 94(3):375-8. PMID: 25307457.
      Citations: 4     Fields:    Translation:Humans
    17. Beider K, Darash-Yahana M, Blaier O, Koren-Michowitz M, Abraham M, Wald H, Wald O, Galun E, Eizenberg O, Peled A, Nagler A. Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo. Mol Cancer Ther. 2014 May; 13(5):1155-69. PMID: 24502926.
      Citations: 23     Translation:HumansAnimalsCells
    18. Koren-Michowitz M, Buzaglo Z, Ribakovsky E, Schwarz M, Pessach I, Shimoni A, Beider K, Amariglio N, le Coutre P, Nagler A. OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients. Eur J Haematol. 2014 Apr; 92(4):283-8. PMID: 24215657.
      Citations: 8     Fields:    Translation:Humans
    19. Koren-Michowitz M, Gery S, Tabayashi T, Lin D, Alvarez R, Nagler A, Koeffler HP. SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F. Br J Haematol. 2013 Jun; 161(6):811-20. PMID: 23590807.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    20. Lin DC, Yin T, Koren-Michowitz M, Ding LW, Gueller S, Gery S, Tabayashi T, Bergholz U, Kazi JU, Rönnstrand L, Stocking C, Koeffler HP. Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3. Blood. 2012 Oct 18; 120(16):3310-7. PMID: 22942183.
      Citations: 22     Fields:    Translation:AnimalsCells
    21. Koren-Michowitz M, Landman J, Cohen Y, Rahimi-Levene N, Salomon O, Michael M, Amariglio N, Nagler A. JAK2V617F allele burden is associated with transformation to myelofibrosis. Leuk Lymphoma. 2012 Nov; 53(11):2210-3. PMID: 22524513.
      Citations: 10     Fields:    Translation:Humans
    22. Koren-Michowitz M, Volchek Y, Naparstek E, Gavish I, Levi I, Rowe JM, Shimoni A, Nagler A. Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC. Hematol Oncol. 2012 Dec; 30(4):200-5. PMID: 22241698.
      Citations: 10     Fields:    Translation:Humans
    23. Hardan I, Stanevsky A, Volchek Y, Tohami T, Amariglio N, Trakhtenbrot L, Koren-Michowitz M, Shimoni A, Nagler A. Treatment with interferon alpha prior to discontinuation of imatinib in patients with chronic myeloid leukemia. Cytokine. 2012 Feb; 57(2):290-3. PMID: 22169779.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    24. Koren-Michowitz M, Sato-Otsubo A, Nagler A, Haferlach T, Ogawa S, Koeffler HP. Older patients with normal karyotype acute myeloid leukemia have a higher rate of genomic changes compared to young patients as determined by SNP array analysis. Leuk Res. 2012 Apr; 36(4):467-73. PMID: 22071139.
      Citations: 4     Fields:    Translation:Humans
    25. Avni B, Koren-Michowitz M. Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol. 2011 Oct; 2(5):309-16. PMID: 23556098.
      Citations: 57     
    26. Chan D, Koren-Michowitz M. Update on JAK2 Inhibitors in Myeloproliferative Neoplasm. Ther Adv Hematol. 2011 Apr; 2(2):61-71. PMID: 23556077.
      Citations: 1     
    27. Koren-Michowitz M, le Coutre P, Duyster J, Scheid C, Panayiotidis P, Prejzner W, Rowe JM, Schwarz M, Goldschmidt N, Nagler A. Activity and tolerability of nilotinib: a retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerant. Cancer. 2010 Oct 01; 116(19):4564-72. PMID: 20572041.
      Citations: 11     Fields:    Translation:Humans
    28. Gueller S, Goodridge HS, Niebuhr B, Xing H, Koren-Michowitz M, Serve H, Underhill DM, Brandts CH, Koeffler HP. Adaptor protein Lnk inhibits c-Fms-mediated macrophage function. J Leukoc Biol. 2010 Oct; 88(4):699-706. PMID: 20571037.
      Citations: 12     Fields:    Translation:AnimalsCells
    29. Thoennissen NH, Krug UO, Lee DH, Kawamata N, Iwanski GB, Lasho T, Weiss T, Nowak D, Koren-Michowitz M, Kato M, Sanada M, Shih LY, Nagler A, Raynaud SD, Müller-Tidow C, Mesa R, Haferlach T, Gilliland DG, Tefferi A, Ogawa S, Koeffler HP. Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood. 2010 Apr 08; 115(14):2882-90. PMID: 20068225.
      Citations: 50     Fields:    Translation:HumansCellsCTClinical Trials
    30. Trakhtenbrot L, Hardan I, Koren-Michowitz M, Oren S, Yshoev G, Rechavi G, Nagler A, Amariglio N. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma. Genes Chromosomes Cancer. 2010 Jan; 49(1):17-27. PMID: 19787791.
      Citations: 5     Fields:    Translation:HumansCells
    31. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, Paz N, Koren-Michowitz M, Waldman D, Leider-Trejo L, Toren A, Constantini S, Rechavi G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009 Feb 17; 6(2):e1000029. PMID: 19226183.
      Citations: 291     Fields:    Translation:HumansCells
    32. Berger R, Rotem-Yehudar R, Slama G, Landes S, Kneller A, Leiba M, Koren-Michowitz M, Shimoni A, Nagler A. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res. 2008 May 15; 14(10):3044-51. PMID: 18483370.
      Citations: 268     Fields:    Translation:HumansCTClinical Trials
    33. Koren-Michowitz M, Shimoni A, Vivante A, Trakhtenbrot L, Rechavi G, Amariglio N, Loewenthal R, Nagler A, Cohen Y. A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). Leuk Res. 2008 Mar; 32(3):421-7. PMID: 17698191.
      Citations: 10     Fields:    Translation:Humans
    34. Koren-Michowitz M, Hardan I, Berghoff J, Yshoev G, Amariglio N, Rechavi G, Nagler A, Trakhtenbrot L. Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis. Cancer Lett. 2007 Oct 08; 255(2):307-14. PMID: 17590504.
      Citations: 2     Fields:    Translation:HumansCells
    35. Koren-Michowitz M, Rahimi-Levene N, Volcheck Y, Hardan I, Kornberg A. Rituximab monotherapy as interim therapy in precursor B-ALL adults during periods of hepatic toxicity: report of two cases. Am J Hematol. 2006 Dec; 81(12):979-80. PMID: 17019690.
      Citations: 3     Fields:    Translation:Humans
    36. Chanimov M, Koren-Michowitz M, Cohen ML, Pilipodi S, Bahar M. Tumor lysis syndrome induced by dexamethasone. Anesthesiology. 2006 Sep; 105(3):633-4. PMID: 16932011.
      Citations: 6     Fields:    Translation:Humans
    37. Shemesh E, Koren-Michowitz M, Yehuda R, Milo-Cotter O, Murdock E, Vered Z, Shneider BL, Gorman JM, Cotter G. Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. Psychosomatics. 2006 May-Jun; 47(3):231-9. PMID: 16684940.
      Citations: 17     Fields:    Translation:Humans
    38. Koren-Michowitz M, Rahimi-Levene N, Volcheck Y, Garach-Jehoshua O, Kornberg A. Protein Z and its role in venous and arterial thrombosis. Isr Med Assoc J. 2006 Jan; 8(1):53-5. PMID: 16450754.
      Citations: 1     Fields:    Translation:Humans
    39. Koren-Michowitz M, Eting E, Rahimi-Levene N, Garach-Jehoshua O, Volcheck Y, Kornberg A. Protein Z levels and central retinal vein or artery occlusion. Eur J Haematol. 2005 Nov; 75(5):401-5. PMID: 16191090.
      Citations: 7     Fields:    Translation:Humans
    40. Michowitz Y, Shiloach E, Horowitz M, Koren-Michowitz M, Sandbank J, Rapoport MJ. [Transient lower limbs paralysis--a rare presenting symptom of Sjögren's syndrome]. Harefuah. 2005 Apr; 144(4):241-2, 304. PMID: 15889604.
      Citations:    Fields:    Translation:Humans
    41. Koren-Michowitz M, Dishy V, Zaidenstein R, Yona O, Berman S, Weissgarten J, Golik A. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study. Am J Hypertens. 2005 Mar; 18(3):358-63. PMID: 15797654.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    42. Koren-Michowitz M, Avni B, Michowitz Y, Moravski G, Efrati S, Golik A. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study. Pharmacoepidemiol Drug Saf. 2004 May; 13(5):299-302. PMID: 15133781.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    43. Weiss M, Koren-Michowitz M, Segal E, Ish-Shalom S. Monitoring response to osteoporosis therapy with alendronate by a multisite ultrasound device: a prospective study. J Clin Densitom. 2003; 6(3):219-24. PMID: 14514990.
      Citations: 2     Fields:    Translation:Humans